SEC Filing Details
Document Details
Form
Filing Date
Feb 9, 2024
Document Date
Feb 9, 2024
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Apogee Therapeutics, Inc.
Issuer
APOGEE THERAPEUTICS, INC.